共 83 条
[1]
O’Brien SG(2003)Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia N Engl J Med. 348 994-1004
[2]
Guilhot F(2011)Practical management of patients with chronic myeloid leukemia Cancer. 117 4343-54
[3]
Larson RA(2010)Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation Hematology Am Soc Hematol Educ Program. 2010 368-76
[4]
Gathmann I(2011)Controversies in the treatment of CML in children and adolescents: TKIs versus BMT? Biol Blood Marrow Transplant. 17 S115-22
[5]
Baccarani M(2012)How I treat childhood CML Blood. 119 1821-30
[6]
Cervantes F(2004)Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children’s Oncology Group phase 1 study Blood. 104 2655-60
[7]
Cervantes F(2011)Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial J Clin Oncol. 29 2827-32
[8]
Mauro M(2010)Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia Haematologica. 95 e4-92
[9]
Suttorp M(2006)Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation Leukemia. 20 187-62
[10]
Millot F(2011)Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children’s Oncology Group Pediatr Blood Cancer. 57 56-9